VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 144 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $45,623 | -59.4% | 4,869 | +6.4% | 0.00% | -60.0% |
| Q2 2023 | $112,249 | +1.2% | 4,576 | +4.4% | 0.01% | 0.0% |
| Q4 2022 | $110,908 | +31.3% | 4,382 | 0.0% | 0.01% | +25.0% |
| Q3 2022 | $84,485 | -24.3% | 4,382 | 0.0% | 0.00% | -20.0% |
| Q2 2022 | $111,610 | +11.0% | 4,382 | +12.1% | 0.01% | +25.0% |
| Q1 2022 | $100,565 | -84.4% | 3,910 | -74.7% | 0.00% | -55.6% |
| Q4 2021 | $646,640 | -8.7% | 15,444 | -5.1% | 0.01% | -10.0% |
| Q3 2021 | $708,114 | -8.1% | 16,271 | +8.3% | 0.01% | -16.7% |
| Q1 2021 | $770,280 | +83.3% | 15,024 | -4.3% | 0.01% | +100.0% |
| Q4 2020 | $420,205 | -22.0% | 15,691 | 0.0% | 0.01% | -33.3% |
| Q3 2020 | $538,672 | -7.5% | 15,691 | +10.4% | 0.01% | -10.0% |
| Q2 2020 | $582,348 | +580.0% | 14,214 | +468.8% | 0.01% | +400.0% |
| Q1 2020 | $85,641 | – | 2,499 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SB INVESTMENT ADVISERS (UK) LTD | 22,616,666 | $284,405,000 | 3.12% |
| INDUS CAPITAL PARTNERS, LLC | 681,936 | $8,575,000 | 1.68% |
| Alphabet Inc. | 1,666,666 | $20,958,000 | 1.27% |
| Temasek Holdings (Private) Ltd | 5,499,999 | $69,162,000 | 0.45% |
| Board of Trustees of The Leland Stanford Junior University | 38,905 | $490,000 | 0.06% |
| Baillie Gifford | 500,000 | $6,287,000 | 0.01% |
| Marshall Wace North America L.P. | 74,898 | $941,000 | 0.01% |
| Capital International Investors | 983,300 | $12,365,000 | 0.00% |
| Blackstone Inc. | 35,000 | $440,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,908 | $24,000 | 0.00% |